CD300d polyclonal antibody

• Background :

  Predicted to enable transmembrane signaling receptor activity and virus receptor activity. Predicted to be involved in immune system process. Predicted to act upstream of or within regulation of interleukin-6 production and regulation of tumor necrosis factor production. Predicted to be integral component of membrane. Predicted to be active in plasma membrane.

• Structure Composition :

  Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.

• Product Name Alternative :

  CD300LD; CD300D; CMRF35A4; CMRF35-like molecule 4; CLM-4; CD300 antigen-like family member D; CMRF35-A4; CD300d

• Swiss Prot :

  Q6UXZ3

• Reactivity :

  Human

• Immunogen :

  The antiserum was produced against synthesized peptide derived from the Internal region of human CD300LD. AA range:61-110

• Conjugation :

  Unconjugated

• Applications :

  WB, ELISA

• Dilution :

  WB: 1/500-1/1000 ELISA: 1/10000

• Purity :

  Affinity Purified

• Modification :

  Unmodified

• Molecular Weight :

  Calculated MW: 22 kDa; Observed MW: 22 kDa

• Storage Conditions :

  Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

• Notes :

  For research use only, not for use in diagnostic procedure.

• Specificity :

  IgG

• Applications Notes :

  Western blot analysis of CD300d in NIH3T3 lysates using CD300d antibody.

• Host or Source :

  Rabbit

• CAS Number :

  9007-83-4